TREATMENT CORRELATION OF SIDEROPENIC ANEMIA WITH IRON (III) PROTEIN SUCCINYLATE (IPS) AND SUCROSOMIAL IRON (SI)
Journal Title: Acta Medica Balkanica - International Journal of Medical Sciences - Year 2019, Vol 4, Issue 7
Abstract
Introduction: Anaemia denotes a reduced number of erythrocytes or reduced amount of Hgb, or one and the other at the simultaneously, below the reference values for the appropriate age. Iron is a metal taken-in by ingestion and it is crucial for haemoglobin synthesis, and saturation of its storage. During the different ages of life, and in infants also, the daily iron needs increases, and if this need is not compensated, hypochromic anaemia develops. Purpose: This paper aims to determine the time ratio and the results of the treatment of iron-deficiency anaemia with IronProteinSuccinylate and Sucrosomial Iron. Materials and Methods: The prospective study was performed during the screening of anaemia in infants at the PHI – PEDIATRIKA in Tetovo and the clinical laboratory at the Clinical Hospital of Tetovo; 76 infants aged 1- 12 months were screened, diagnosed with anaemia and treated during the period of January – June 2018. At the average age of 7.4 months, the gender composition was as follows: 47 infants are females, and 29 are males. Results: The results obtained at the beginning and after treatment with anti-anaemia therapy in both groups were analysed. The group that had been treated with Sucrosomial Iron has shown significant improvement of some parameters such as Hgb, HTC, MCV and Fe++ after using therapy for 1 month, while the group of patients treated with Iron Protein Succinylate has had a significantly weaker improvement compared to the first group. Conclusion: Sucrosomial Irontreatment has been shown to be most effective in the largest percentage of patients with Iron-deficiency anaemia, with parameters such as Hgb, HCT, MCV and Fe++ having higher growth in the group treated with Sucrosomial Iron for a period of 1 month. Discussion: The infant’s feeding habits are very important and affect the results of the treatment of anaemia; iron- rich food products and the use of supplementary therapy that is known of not having side effects, and that shortens the treatment period are recommended.
Authors and Affiliations
Sani Bajrami, Anita Sinani, Florin Besimi, Destan Haliti
Keywords
Related Articles
- EP ID EP655600
- DOI -
- Views 156
- Downloads 0
THE VALUES OF CARDIAC TROPONIN IN ACUTE CORONARY SYNDROME
Acute Coronary Syndrome (ACS) is the factor with the highest rate of morbidity and mortality. ACS compromises Myocardial Infarction (MI), and Unstable Angina or sharp, sudden chest pain which typically appears when the p...
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND RENAL DISEASES
Non-steroidal anti-inflammatory drugs (NSAIDs) have always been used to treat pain, even though studies exist reporting and verifying undesirable effects especially nephrotoxicity and alimentary tract toxicity. The mecha...
THE ALTERATIONS OF THE ENZYMATIC ANTIOXYDANT ACTIVITY BY ADDING ALKALINE WATER ON THE WHITE LABORATORY RATS AFTER HYPERTHERMIC STRESS
Alkaline water is in the focus of scientific interest over the last decade, due to its ability to alkalize the organism as well as its antioxidant effect. Due the hyperthermia, systemic and cellular changes occurs. Addin...
USE OF ANTIBIOTICS IN UPPER AND LOWER RESPIRATORY TRACT INFECTIONS
Introduction: Inflammatory respiratory diseases in childhood are frequent occurrences and account for about 70% of the general morbidity in childhood. Differentiating bacterial and viral infections as well as their early...
OUTCOME OF NEUROBRUCELLOSIS FOCUSED ON TREATMENT
Background: This study aimed to analyze the outcome of neurobrucellosis according to treatment. Material/Methods: A cross-sectional epidemiologic survey was carried out in 648 patients with brucellosis hospitalized in In...